New injection promotes fat cell elimination
Initial clinical trials have shown that the new treatment "CBL-514" is effective in weight loss by safely destroying fat cells rather than merely reducing their size. The trials involved hundreds of participants over a period of 12 weeks, with those receiving the treatment experiencing a 12.01% reduction in visceral fat compared to a 5.68% increase in the placebo group. In addition to aesthetic improvements, the treatment contributes to better blood pressure and cholesterol levels, demonstrating an ability to reduce weight regain when used alongside "GLP-1" medications, as it completely eliminates fat cells. Broader studies are currently underway to verify the sustainability of these results and ensure long-term safety.
Notice: This Is an AI-Generated Summary
Comments (0)